Cryosite Company Description
Cryosite Limited provides outsourced clinical trials logistic services in Australia.
It operates through Ambient, cold, and frozen, Ultra-frozen and cryogenic, and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements.
The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage.
The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls.
It also, offers reverse logistics services, secondary packaging, and quality transportation and distribution solutions.
Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.
Country | Australia |
Founded | 1999 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 25 |
Contact Details
Address: 13a Ferndell Street South Granville, New South Wales 2142 Australia | |
Phone | 61 2 8865 2000 |
Website | cryosite.com |
Stock Details
Ticker Symbol | CTE |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000CTE1 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Jane Hao | Chief Financial Officer |
Hamish George | Company Secretary |